A study to see the efficacy of sympathetic nerve block in management of head, neck cancer pain.
Phase 4
- Conditions
- Health Condition 1: C14- Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
- Registration Number
- CTRI/2020/04/024562
- Lead Sponsor
- ESI Institute of Pain Management
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All head, neck ,upper extremity & chest wall region cancer patients having pain.
2.pain score NRS 6 or above.
3.Received pharmacological treatment for at least 4 weeks for pain management.
Exclusion Criteria
1.Infection
2.Coagulation disorders.
3.Psychiatric disorder patients
4.Those who have Respiratory diseases.
5.Patients with a history of vocal cord paralysis on the non-surgical side, patients with a history of severe difficulty swallowing
6.Patients with distorted neck anatomy
7.Patients suffering from any type of cardiac disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain score using NRSTimepoint: Prior to the procedure and after 7 days and 1 month after the procedure.
- Secondary Outcome Measures
Name Time Method EQ5D QuestionnaireTimepoint: Prior to the procedure and after 7 days and 1 month after the procedure.